Bluebird bio (BLUE) shares continued their downward descent Monday following news that the company plans to be taken private through a deal valued at up to $96M. Read more here.
Q4 2024 Earnings Call Transcript February 13, 2025 Operator: Good morning, and welcome to Agios’ Fourth Quarter 2024 ...
Crispr Therapeutics AG has revenue declines but holds strong financials. Promising Sickle Cell therapy & 2025 data readouts ...
Good day, and welcome to the Vertex Pharmaceuticals fourth quarter 2024 earnings call. All participants will be in a ...
After Tina Crawford’s only child was gunned down in a robbery, she vowed revenge. But when one of the convicted killers wrote ...
Q4 2024 Earnings Call Transcript February 10, 2025 Vertex Pharmaceuticals Incorporated misses on earnings expectations. Reported EPS is $3.98 EPS, expectations were $4.02. Operator: Good day, and ...
So she gathered his family and friends and they grilled and drank and played volleyball and listened to music and did the Cha-Cha Slide ... the hospital for her sickle-cell anemia.
6don MSN
The high cost of sickle cell gene therapies is pushing private insurers and Medicaid programs to develop new payment models.
In December 2023, through the development efforts of CRISPR Therapeutics and Vertex Pharmaceuticals, their decades-long ...
Gallbladder problems are a common complication in individuals with sickle cell disease. These issues often arise due to the breakdown of red blood cells and the subsequent formation of gallstones ...
On Tuesday, the Buffalo community came together to spread awareness about sickle cell disease during Black History Month.
A "groundbreaking" £1.65 million treatment has been approved for use on the NHS, offering patients with severe sickle cell disease some hope of a cure. It is believed around 1,700 people could be ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results